Skip to main content
Caplight Logo









2cureX

2cureX

Private
CopenhagenHealthcare & Life Scienceshttps://www.2curex.se/

Last Round

Private Placement

Apr 22, 2026

Est. Valuation

$3.8M

Total Funding Raised

$10.34M

Company Overview

2cureX is a medical technology company that develops functional drug sensitivity testing solutions, including its proprietary IndiTreat platform, to provide personalized cancer treatment decisions.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

precision medicinecancer diagnosticsdrug sensitivity testingtumoroidsfunctional oncologypersonalized cancer therapy3D tumor modelsin-vitro assayscancer drug screeningorganoid technologyclinical decision supportdiagnostic platformmedical diagnosticsbiotechlab-on-a-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

2cureX Comparables

Compare 2cureX with similar companies based on industry and business-model similarity.

2cureX comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PreComb Therapeutics
86%
SpheroTec GmbH
84%
VitroScan
83%

2cureX Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementApr 22, 2026
DebtJun 17, 2024
Private PlacementJun 17, 2024
GrantFeb 1, 2021
Private PlacementJul 6, 2020
Grant
Apr 1, 2020

2cureX Investors

Notable investors and investment history

2cureX investors
InvestorRounds
KoodosPrivate Placement
Kinled HoldingDebt, Private Placement

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2024

    $3.2M round led by Kinled Holding

  • Jun 17, 2024

    $260K round led by Kinled Holding

2cureX Filings

Explore SEC and related filing metadata, where available.

2cureX filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about 2cureX's valuation, stock price, and market status.

Is 2cureX a public or private company?

2cureX is a private company.

What is the current stock price of 2cureX?

2cureX is a private company with no public stock price. No recent secondary market data is available.

How much is 2cureX worth (valuation)?

2cureX's valuation is estimated at $3.8M based on funding round data.

Can I buy 2cureX stock?

2cureX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was 2cureX's last funding round?

2cureX's most recent funding round was Private Placement on April 22, 2026.

Who are the main investors in 2cureX?

Key investors in 2cureX include Kinled Holding.

Will 2cureX IPO soon?

No public IPO plans have been announced for 2cureX.

How can I track 2cureX secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor 2cureX's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCopenhagen
Year Founded2006
Last FundingApr 22, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?